| 1 | Mineralocorticoid receptor antagonists in diabetic kidney disease ? mechanistic and therapeutic effects | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Lima-Posada, Ixchel, Bakris, George L., Jaisser, Frederic | 2022 | NATURE REVIEWS NEPHROLOGY | WoS-id: 000709772900001
Scopus-id: 2-s2.0-85117458052
| 187 | 194 |
| 2 | The mineralocorticoid receptor in chronic kidney disease | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Jaisser, Frederic, Anders, Hans-Joachim | 2022 | BRITISH JOURNAL OF PHARMACOLOGY | WoS-id: 000735235000001
Scopus-id: 2-s2.0-85121922154
| 26 | 32 |
| 3 | Hepatocyte growth factor reverses cholemic nephropathy associated with alpha-naphthylisothiocyanate-induced cholestasis in mice | Coautor: Barrera-Chimal, Jonatan, Salas-Silva, Soraya, Lopez-Ramirez, Jocelyn, Lazzarini-Lechuga, Roberto, et al. | 2022 | LIFE SCIENCES | WoS-id: 000777798500003
Scopus-id: 2-s2.0-85124883982
| 0 | 1 |
| 4 | Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease | Coautor: Barrera-Chimal, Jonatan, Nakamura, Toshifumi, Girerd, Sophie, Jaisser, Frederic | 2022 | KIDNEY INTERNATIONAL SUPPLEMENTS | WoS-id: 000783935400003
Scopus-id: 2-s2.0-85125864616
| 37 | 34 |
| 5 | Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Bonnard, Benjamin, Jaisser, Frederic | 2022 | Annual Review of Physiology | WoS-id: 000789888500025
Scopus-id: 2-s2.0-85124500191
| 66 | 71 |
| 6 | Editorial: Targeting Dysregulated Inflammation to Treat Cardiovascular Diseases | Coautor: Barrera-Chimal J., Buelna-Chontal M., Bansal S.S., Liberale L. | 2022 | Frontiers In Cell And Developmental Biology | WoS-id: 000805441100001
Scopus-id: 2-s2.0-85131586100
| 2 | 2 |
| 7 | The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease | 1ᵉʳ autor: Barrera-Chimal J., Gerarduzzi C., Rossignol P., Jaisser F. | 2022 | CLINICAL SCIENCE | WoS-id: 000821858600001
Scopus-id: 2-s2.0-85133104890
| 13 | 12 |
| 8 | Oxidized albumin as a mediator of kidney disease | Coautor: Barrera-Chimal J., Figueroa S.M., Araos P., Reyes J., et al. | 2021 | Antioxidants | WoS-id: 000633340400001
Scopus-id: 2-s2.0-85102132113
| 30 | 31 |
| 9 | MR (Mineralocorticoid Receptor) in Endothelial Cells: A Major Contributor in Pulmonary Arterial Hypertension Remodeling | 1ᵉʳ autor: Barrera-Chimal J., Jaisser F. | 2021 | Hypertension | WoS-id: 000670393600026
Scopus-id: 2-s2.0-85109518952
| 3 | 3 |
| 10 | Editorial: Kidney and Distant Organ Crosstalk in Health and Disease | Coautor y autor de correspondencia: Barrera-Chimal, Jonatan, Lopez-Andres, Natalia, Jaisser, Frederic | 2021 | FRONTIERS IN PHYSIOLOGY | WoS-id: 000673724000001
Scopus-id: 2-s2.0-85110592858
| 2 | 2 |
| 11 | Chronic Kidney Disease Induced by Cisplatin, Folic Acid and Renal Ischemia Reperfusion Induces Anemia and Promotes GATA-2 Activation in Mice | Coautor: Barrera-Chimal, Jonatan, Estrela, Gabriel Rufino, Freitas-Lima, Leandro Ceotto, Budu, Alexandre, et al. | 2021 | Biomedicines | WoS-id: 000677340400001
Scopus-id: 2-s2.0-85110459808
| 15 | 18 |
| 12 | Early inflammatory changes and CC chemokine ligand-8 upregulation in the heart contribute to uremic cardiomyopathy | Coautor: Barrera-Chimal, Jonatan, Amador-Martinez, Isabel, Garcia-Ballhaus, Johannes, Buelna-Chontal, Mabel, et al. | 2021 | FASEB JOURNAL | WoS-id: 000678975300042
Scopus-id: 2-s2.0-85111398498
| 10 | 10 |
| 13 | Renal fibrosis due to multiple cisplatin treatment is exacerbated by kinin B1 receptor antagonism | Coautor: Barrera-Chimal, J., Budu, A., Freitas-Lima, L. C., de Arruda, A. C., et al. | 2021 | Brazilian Journal Of Medical And Biological Research | WoS-id: 000710522900001
Scopus-id: 2-s2.0-85117965749
| 5 | 7 |
| 14 | DELETION AND BLOCKAGE OF KININ B1 RECEPTOR EXACERBATES CISPLATIN-INDUCED CKD | Coautor: Barrera-Chimal, Jonatan, Estrela, Gabriel, Budu, Alexandre, Freitas-Lima, Leandro, et al. | 2021 | NEPHROLOGY DIALYSIS TRANSPLANTATION | WoS-id: 000713465600008
| 0 | 0 |
| 15 | Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Kolkhof, Peter, Lima-Posada, Ixchel, Joachim, Alexandre, et al. | 2021 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | WoS-id: 000727167500001
Scopus-id: 2-s2.0-85121316240
| 44 | 48 |
| 16 | Vascular and inflammatory mineralocorticoid receptors in kidney disease | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Jaisser, Frederic | 2020 | ACTA PHYSIOLOGICA | WoS-id: 000488554500001
Scopus-id: 2-s2.0-85073953679
| 8 | 9 |
| 17 | Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Jaisser, Frederic | 2020 | DIABETES OBESITY & METABOLISM | WoS-id: 000524725600002
Scopus-id: 2-s2.0-85083048126
| 126 | 129 |
| 18 | HGF induces protective effects in a-naphthylisothiocyanate-induced intrahepatic cholestasis by counteracting oxidative stress | Coautor: Barrera-Chimal, Jonatan, Salas-Silva, Soraya, Simoni-Nieves, Arturo, Razori M.V., et al. | 2020 | BIOCHEMICAL PHARMACOLOGY | WoS-id: 000527342900024
Scopus-id: 2-s2.0-85078183313
| 18 | 19 |
| 19 | Physical Exercise Exacerbates Acute Kidney Injury Induced by LPS via Toll-Like Receptor 4 | Coautor: Barrera-Chimal, Jonatan, Húngaro T.G.R., Freitas-Lima, Leandro Ceotto, Gregnani, Marcos Fernandes, et al. | 2020 | FRONTIERS IN PHYSIOLOGY | WoS-id: 000560104400001
Scopus-id: 2-s2.0-85088951687
| 11 | 14 |
| 20 | THE IMPORTANCE OF PPAR-ALPHA IN AKI TO CKD TRANSITION IN NEPHROPATHY INDUCED BY FOLIC ACID | Coautor: Barrera-Chimal, Jonatan, Estrela, Gabriel, Arruda, Adriano, Freitas-Lima, Leandro, et al. | 2020 | NEPHROLOGY DIALYSIS TRANSPLANTATION | WoS-id: 000562392100772
| 0 | 0 |
| 21 | Ppar-a deletion attenuates cisplatin nephrotoxicity by modulating renal organic transporters mate-1 and oct-2 | Coautor: Barrera-Chimal, Jonatan, Freitas-Lima, Leandro Ceotto, Budu, Alexandre, Arruda, Adriano Cleis, et al. | 2020 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | WoS-id: 000586494800001
Scopus-id: 2-s2.0-85092784919
| 33 | 39 |
| 22 | HGF protector effect in intrahepatic cholestasis | Coautor: Barrera Chimal, Jonatan, Salas Silva, Elsy Soraya, Simoni Nieves, Arturo, Valeria Razori, Maria, et al. | 2019 | JOURNAL OF HEPATOLOGY | WoS-id: 000463481701420
| 0 | 0 |
| 23 | Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed | Coautor: Barrera-Chimal, Jonatan, Melis, Nicolas, Thuillier, Raphael, Steichen, Clara, et al. | 2019 | EXPERT OPINION ON THERAPEUTIC TARGETS | WoS-id: 000467944500005
Scopus-id: 2-s2.0-85065416303
| 13 | 12 |
| 24 | Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation | 1ᵉʳ autor: Barrera-Chimal J., Rocha L., Amador-Martínez I., Pérez-Villalva R., et al. | 2019 | NEPHROLOGY DIALYSIS TRANSPLANTATION | WoS-id: 000473748300011
Scopus-id: 2-s2.0-85065667130
| 46 | 44 |
| 25 | Randomized Controlled Trial Of Spironolactone Effect In Kidney Transplant Recipients Of Living Donors. | Coautor: Barrera-Chimal, J., Bobadilla, N. A., Morales-Buenrostro, L. E., Ortega-Trejo, J. A., et al. | 2019 | AMERICAN JOURNAL OF TRANSPLANTATION | WoS-id: 000474897602091
| 2 | 0 |
| 26 | Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Girerd, Sophie, Jaisser, Frederic | 2019 | KIDNEY INTERNATIONAL | WoS-id: 000476628300012
Scopus-id: 2-s2.0-85066071478
| 207 | 222 |
| 27 | The absence of endothelial sodium channel a (aENaC) reduces renal ischemia/reperfusion injury | Coautor: Barrera-Chimal, Jonatan, Tarjus, Antoine, Gonzalez-Rivas, Cecilia, Amador-Martinez, Isabel, et al. | 2019 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | WoS-id: 000477041100020
Scopus-id: 2-s2.0-85068926596
| 19 | 21 |
| 28 | Reduced endothelial nitric oxide synthase activation contributes to cardiovascular injury during chronic kidney disease progression | Coautor: Barrera-Chimal, Jonatan, Amador-Martinez, Isabel, Perez-Villalva, Rosalba, Uribe, Norma, et al. | 2019 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | WoS-id: 000481592600006
Scopus-id: 2-s2.0-85070181660
| 32 | 31 |
| 29 | Spironolactone reduces oxidative stress in living donor kidney transplantation: A randomized controlled trial | Coautor: Barrera-Chimal, Jonatan, Morales-Buenrostro L.E., Ortega-Trejo J.A., Perez-Villalva, Rasalba, et al. | 2019 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | WoS-id: 000486411500001
Scopus-id: 2-s2.0-85071700310
| 22 | 23 |
| 30 | Vascular mineralocorticoid receptor activation and disease | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Jaisser, Frederic | 2019 | EXPERIMENTAL EYE RESEARCH | WoS-id: 000494503700026
Scopus-id: 2-s2.0-85072156452
| 20 | 20 |
| 31 | Resilience to acute kidney injury in offspring of maternal protein restriction | 2ᵒ autor: Barrera-Chimal, Jonatan, Enrique Garcia-Ortuno, Luis, Perez-Villalva, Rosalba, Antonio Ortega-Trejo, Juan, et al. | 2019 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | WoS-id: 000500554500024
Scopus-id: 2-s2.0-85075957144
| 8 | 8 |
| 32 | The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Estrela, Gabriel R., Lechner, Sebastian M., Giraud, Sebastien, et al. | 2018 | KIDNEY INTERNATIONAL | WoS-id: 000432465400015
Scopus-id: 2-s2.0-85043484077
| 148 | 153 |
| 33 | The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway | Coautor: Barrera-Chimal, Jonatan, Bazua-Valenti, Silvana, Rojas-Vega, Lorena, Castaneda-Bueno, Maria, et al. | 2018 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | WoS-id: 000437901600009
Scopus-id: 2-s2.0-85049407534
| 36 | 37 |
| 34 | Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction | 2ᵒ autor: Barrera-Chimal J., Lachaux M., Nicol L., Rémy-Jouet I., et al. | 2018 | DIABETES OBESITY & METABOLISM | WoS-id: 000444185800009
Scopus-id: 2-s2.0-85053080463
| 45 | 46 |
| 35 | Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1 | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Andre-Gregoire, Gwennan, Cat, Aurelie Nguyen Dinh, Lechner, Sebastian M., et al. | 2017 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | WoS-id: 000397832900023
Scopus-id: 2-s2.0-85021661134
| 76 | 81 |
| 36 | Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease Role of Oxidative Stress | Coautor: Barrera-Chimal, Jonatan, Lattenist, Lionel, Lechner, Sebastian M., Messaoudi, Smail, et al. | 2017 | Hypertension | WoS-id: 000399323800024
Scopus-id: 2-s2.0-85015807935
| 115 | 119 |
| 37 | Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy | Coautor: Barrera-Chimal, Jonatan, Medeiros, Mara, Velasquez-Jones, Luis, Hernandez, Ana M., et al. | 2017 | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | WoS-id: 000407053500013
Scopus-id: 2-s2.0-85026921596
| 30 | 30 |
| 38 | HSP72 is an early biomarker to detect cisplatin and acetaminophen nephrotoxicity | 2ᵒ autor: Barrera-Chimal J., Pérez-Villalva R., Aguilar-Carrasco J.C., Lima-Posada I., et al. | 2017 | Biomarkers | WoS-id: 000407243800007
Scopus-id: 2-s2.0-85017640273
| 11 | 11 |
| 39 | Myeloid Mineralocorticoid Receptor Controls Inflammatory and Fibrotic Responses After Renal Ischemic Injury via Macrophage Interleukin-4 Receptor. | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Lechner, Sebastian M., Moghrabi, Soumaya E., Kolkhof, Peter, et al. | 2017 | Hypertension | WoS-id: 000523486000112
| 0 | 0 |
| 40 | Sub-chronic exposure to fluoride impacts the response to a subsequent nephrotoxic treatment with gentamicin | Coautor: Barrera-Chimal, Jonatan, Cardenas-Gonzalez, Mariana, Jacobo Estrada, Tania, Rodriguez-Munoz, Rafael, et al. | 2016 | JOURNAL OF APPLIED TOXICOLOGY | WoS-id: 000368144500012
Scopus-id: 2-s2.0-84954366996
| 13 | 13 |
| 41 | Sulfenic acid modification of endothelin b receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia | 1ᵉʳ autor: Barrera-Chimal J., Prince S., Fadel F., El Moghrabi S., et al. | 2016 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | WoS-id: 000368957600011
Scopus-id: 2-s2.0-84970925334
| 50 | 53 |
| 42 | AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease | Coautor: Barrera-Chimal, Jonatan, Rodriguez-Romo, Roxana, Benitez, Kenia, Perez-Villalva, Rosalba, et al. | 2016 | KIDNEY INTERNATIONAL | WoS-id: 000369775300016
Scopus-id: 2-s2.0-84945561517
| 86 | 91 |
| 43 | Mineralocorticoid Receptor Antagonism: A Promising Therapeutic Approach to Treat Ischemic AKI | 1ᵉʳ autor: Barrera-Chimal, Jonatan, Bobadilla, Norma A., Jaisser, Frederic | 2016 | NEPHRON | WoS-id: 000383421000003
Scopus-id: 2-s2.0-84961233596
| 8 | 8 |
| 44 | Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant | 2ᵒ autor: Barrera-Chimal J., Ramírez-Sandoval J.C., Simancas P.E., Rojas-Montaño A., et al. | 2014 | Biomarkers | WoS-id: 000330885100010
Scopus-id: 2-s2.0-84893329362
| 11 | 10 |
| 45 | Intra-renal transfection of heat shock protein 90 alpha or beta (Hsp90a or Hsp90ß) protects against ischemia/reperfusion injury | 1ᵉʳ autor: Barrera-Chimal J., Pérez-Villalva R., Ortega J.A., Uribe N., et al. | 2014 | NEPHROLOGY DIALYSIS TRANSPLANTATION | WoS-id: 000331404100013
Scopus-id: 2-s2.0-84896721867
| 20 | 22 |
| 46 | Tubular urinary biomarkers do not identify aetiology of acute kidney injury in kidney transplant recipients | 2ᵒ autor: Barrera-Chimal J., Ramirez-Sandoval J.C., Simancas P.E., Correa-Rotter R., et al. | 2014 | Nephrology | WoS-id: 000336442000007
Scopus-id: 2-s2.0-84901001194
| 15 | 14 |
| 47 | Hsp72 Is a Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients | Coautor: Barrera-Chimal J., Morales-Buenrostro L.E., Salas-Nolasco O.I., Casas-Aparicio, G, et al. | 2014 | PLOS ONE | WoS-id: 000343662500038
Scopus-id: 2-s2.0-84908018551
| 31 | 32 |
| 48 | Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: A double-blind, randomized pilot study | 2ᵒ autor: Barrera-Chimal, J, Ojeda-Cervantes, M, Alberu, J, Perez-Villalva, R, et al. | 2013 | AMERICAN JOURNAL OF NEPHROLOGY | WoS-id: 000318703900010
Scopus-id: 2-s2.0-84876798791
| 43 | 46 |
| 49 | Losartan retards the development of Chronic Kidney Disease (CKD) after an Acute Kidney Injury (AKI) episode | 2ᵒ autor: Barrera-Chimal, J, Rodriguez, R, Bentez, K, Perez-Villalva, R, et al. | 2013 | FASEB JOURNAL | WoS-id: 000319860504266
| 0 | 0 |
| 50 | Opposite Effect of Hsp90 alpha and Hsp90 beta on eNOS Ability to Produce Nitric Oxide or Superoxide Anion in Human Embryonic Kidney Cells | 2ᵒ autor: Barrera-Chimal J., Cortes-González C., Ibarra-Sánchez M., Gilbert M., et al. | 2010 | CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | WoS-id: 000283859000017
Scopus-id: 2-s2.0-78149462688
| 30 | 31 |
ID's SCOPUS 
ORCID's 